MTOR and central nervous system cancer: Temozolomide (TMZ) was shown to induce autophagy in the U251 glioma cell line, based on LC3-I to LC3-II conversion, as well as down-regulation of mTOR activity together with the mTOR downstream targets, S6K, and 4E-BP1.